SCHEMBL19229862

SCHEMBL19229862

Cc1ccc(-c2ncccn2)c(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ PDK2 Q15119 1/20 0.38
▸ CYP19A1 P11511 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ CA2 P00918 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TYR P14679 1/20 0.36
▸ CCR9 P51686 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HCRTR1 O43613 2/20 0.34
▸ HCRTR2 O43614 2/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CCR1 P32246 2/20 0.33
▸ CCR5 P51681 2/20 0.33
▸ CCR8 P51685 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19229865 0.85 CYP19A1 (0.40) ALDH1A1PDK2CYP19A1SMN1; SMN2CCR9
SCHEMBL19229871 0.81 KDM4E (0.44) ALDH1A1SMN1; SMN2POLBLMNACYP1A2
SCHEMBL18196003 0.80 FEN1 (0.40) ALDH1A1ATMHCRTR1HCRTR2CYP1A2
SCHEMBL19229866 0.80 CCR9 (0.46) ALDH1A1CYP19A1SMN1; SMN2CCR9GAA
SCHEMBL4550929 0.76 ALDH1A1 (0.44) ALDH1A1PDK2CYP19A1SMN1; SMN2GAA
SCHEMBL18196011 0.76 CYP1A2 (0.44) ALDH1A1CA2LMNACYP1A2CYP2C9
SCHEMBL19229867 0.74 CYP46A1 (0.47) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL5174545 0.73 ELANE (0.44) ALDH1A1PDK2SMN1; SMN2CA2POLB
SCHEMBL27070680 0.73 RAB9A (0.47) ALDH1A1PDK2CYP19A1SMN1; SMN2GAA
SCHEMBL11996640 0.73 HDAC1 (0.42) ALDH1A1PDK2CYP19A1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233385-A1 PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONIST SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2017-08-17 — — US disclosed
US-20170233385-A1 PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONIST SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233385-A1 PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONIST HCRTR1, HCRTR2, OPRD1 ALDH1A1 1839/4885PDK2 1113/4885CYP19A1 1956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback